EPG Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.22M Buy
19,422
+1,445
+8% +$116K 0.33% 77
2025
Q4
$1.71M Buy
17,977
+445
+3% +$43.6K 0.46% 59
2025
Q3
$1.71M Buy
17,532
+494
+3% +$51.2K 0.47% 59
2025
Q2
$1.83M Buy
17,038
+814
+5% +$82.4K 0.55% 46
2025
Q1
$1.64M Buy
16,224
+574
+4% +$57.8K 0.46% 57
2024
Q4
$1.4M Sell
15,650
-649
-4% -$57.1K 0.37% 73
2024
Q3
$1.37M Buy
+16,299
New +$1.28M 0.34% 80
2024
Q2
Sell
-17,110
Closed -$1.25M 83
2024
Q1
$1.17M Buy
17,110
+170
+1% +$10.9K 0.29% 92
2023
Q4
$1.1M Buy
16,940
+411
+2% +$21.9K 0.29% 91
2023
Q3
$873K Buy
+16,529
New +$867K 0.26% 95

Other funds holding BSX

EPG Wealth Management's BSX Position: Q1 2026 in Review

EPG Wealth Management increased its Boston Scientific (BSX) stake by 8% in Q1 2026, buying an estimated $116K and bringing the position to 19,422 shares worth $1.22M. The position accounts for 0.33% of the portfolio, ranked #77.

EPG Wealth Management first reported a position in BSX in Q3 2023 and has held it in 10 quarters since. The position peaked at $1.83M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • EPG Wealth Management held 19,422 shares of Boston Scientific worth $1.22M as of Q1 2026.
  • EPG Wealth Management bought 1,445 Boston Scientific shares in Q1 2026, an estimated $116K.
  • Boston Scientific made up 0.33% of EPG Wealth Management's portfolio in Q1 2026, its #77 holding.
  • EPG Wealth Management first reported a position in Boston Scientific in Q3 2023 and has held it in 10 quarters since.
  • EPG Wealth Management's Boston Scientific position peaked at $1.83M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on EPG Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.